Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

505
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
505
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

197
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
197
Hazard Ratio01:12

Hazard Ratio

289
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
289
Hindsight Biases01:12

Hindsight Biases

4.0K
Hindsight bias leads you to believe that the event you just experienced was predictable, even though it really wasn’t. In other words, you knew all along that things would turn out the way they did. Can you relate this to the phrase "Hindsight is 20/20" now? 
4.0K
Actuarial Approach01:20

Actuarial Approach

150
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
150
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

13.8K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
13.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison Among Ultra-Thin Coronary Stents: A Network Meta-Analysis.

The American journal of cardiology·2024
Same author

De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis.

BMJ evidence-based medicine·2024
Same author

Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology.

International journal of cardiology·2023
Same author

Corrigendum to 'Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score' [American Journal of Cardiology 206 (2023) 320-329].

The American journal of cardiology·2023
Same author

A Meta-Analysis of Short-Term Outcomes of TAVR versus SAVR in Bicuspid Aortic Valve Stenosis and TAVR Results in Different Bicuspid Valve Anatomies.

Journal of clinical medicine·2023
Same author

Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.

International journal of cardiology·2023
Same journal

LMNA p.Arg225Ter-related cardiomyopathy in long term survivor of diffuse large B-cell lymphoma presenting with reduced left ventricular ejection fraction, conduction disease, atrial tachyarrythmias and recurrent thromboembolism.

Kardiologia polska·2026
Same journal

Antithrombotic therapy after percutaneous closure of paravalvular leaks: Patterns of use and clinical outcomes in a single-center retrospective registry.

Kardiologia polska·2026
Same journal

Implantation of a leadless pacemaker in a patient after suicidal self-extraction of a transvenous pacing system.

Kardiologia polska·2026
Same journal

Limitations of current risk stratification in FLNC truncating variant carriers: A family study with multiple sudden cardiac deaths.

Kardiologia polska·2026
Same journal

Post lumbar spine surgery iliocaval arteriovenous fistula presenting with right heart volume overload and severe tricuspid regurgitation in a young woman.

Kardiologia polska·2026
Same journal

Statin therapy modifies the prognostic value of immune-inflammatory indices in acute HFpEF: Data from the LECRA-HF registry.

Kardiologia polska·2026
See all related articles

Related Experiment Video

Updated: Oct 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

TAVI and risk scores: Looking back while moving forward

Federico Conrotto1, Francesco Bruno2, Fabrizio D'Ascenzo2

  • 1Division of Cardiology, Cardiovascular and Thoracic Department, University of Turin, Città della Salute e della Scienza, Turin, Italy. federico.conrotto@gmail.com.

Kardiologia Polska
|November 30, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.3K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.3K

Related Experiment Videos

Last Updated: Oct 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.3K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.3K